التفاصيل البيبلوغرافية
| العنوان: |
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma. |
| المؤلفون: |
O'Gorman, Peter, Laubach, Jacob P., O'Dwyer, Michael E., Krawczyk, Janusz, Yee, Andrew J., Gilligan, Oonagh, Cahill, Mary R., Rosenblatt, Jacalyn, Quinn, John, Murphy, Philip T., DiPietro, Heidi, Perera, Meegahage Ratnakanthi, Crotty, Gerard M., Cummings, Kristen, Hayden, Patrick J., Browne, Paul, Savell, Alexandra, O'Leary, Hilary M., O'Keeffe, Denis, Masone, Kelly |
| المصدر: |
American Journal of Hematology; May2022, Vol. 97 Issue 5, p562-573, 12p |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder